December 07, 2017
Dicronis succeed in the Venture Kick Finale securing kCHF 100 for proceeding with the development of our novel diagnostic for lymphedema.
Enjoy the reading of the Venture Kick Press Release: https://www.venturekick.ch/index.cfm?CFID=589659771&CFTOKEN=38494970&page=135333&article_id=2989&JumpToAnchor=fgBerichtAnker_5641&BackPage=135424